Antimicrobial agent-3 , CAS No.1902712-34-8

CAS: 1902712-34-8 Cat. No.: A1418488 Formule: C14H11N3OS Poids moléculaire: 269.32
DISPONIBLE À COMMANDE
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Taille
Allemagne (EU)
USA*
Prix
Qté
1mg
A1418488-1mg
Sur commande · 8–12 semaines
Enter a quantity for the sizes you want to add.

Vue d’ensemble

Antimicrobial agent-3 (Compound U10) is an antimicrobial agent against bacterial , fungal and tubercular infections.

Spécifications

Conditions de stockage de stockage
Store at -20°C
Expédié en
Ice chest + Ice pads
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Type d'action
INHIBITOR
Noms et identifiants
Poids moléculaire
269.32

Données avancées

Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculateurs de solution
Avis

Avis des clients

Application Protocols

No tested applications, assay protocols, or recommended conditions are provided in the Product Data for this item.

  • Validated applications, recommended concentrations, and positive controls: Not specified for this item; refer to CoA/Spec Sheet.
  • Please consult your internal SOPs or standard guidelines (e.g., CLSI/EUCAST for antimicrobial susceptibility testing) when designing experiments, and confirm compound identity/purity on receipt to ensure data quality.
Biological Roles

No item-specific biological mechanism or target data are provided. The product name suggests it is intended for antimicrobial research; any discussion below is general background and must not be construed as a claim for this item.

General context (literature):

  • Antimicrobial small molecules can act by disrupting cell wall biosynthesis (e.g., peptidoglycan assembly), protein synthesis (ribosomal binding), DNA replication/repair (gyrase/topoisomerase inhibition), membrane integrity, or key metabolic pathways (folate, isoprenoid, fatty-acid synthesis).
  • Spectrum considerations: Compounds may show activity preferentially against Gram-positive or Gram-negative bacteria depending on permeability/efflux liabilities and target presence; activity against fungi often correlates with ergosterol pathway or cell wall differences.
  • Assay-dependent behavior: Apparent potency can shift with media composition (e.g., divalent cations, serum proteins), inoculum effect, and biofilm state. Track minimum inhibitory concentration (MIC) across standardized media (e.g., CLSI M07/M27 methodologies) for comparability.
  • Resistance liabilities: Common mechanisms include target mutation, enzymatic degradation/modification, efflux upregulation, and decreased uptake. Orthogonal counterscreens and time-kill kinetics help interpret mode-of-action hypotheses.

For this item specifically:

  • Target specificity, MoA, and spectrum: Not specified for this item; refer to CoA/Spec Sheet.
  • Use strictly for laboratory research. Implement appropriate controls (vehicle, known comparator agents) and verify identity/purity analytically prior to biological testing.
Buffer Applications

This product is a small-molecule screening compound and is not a buffering agent. No acid/base characteristics or pKa values are provided.

  • If preparing assay media or buffers for biological testing, select established buffer systems (e.g., phosphate, HEPES, MOPS) appropriate to the organism and assay temperature, and validate compatibility with the compound’s solubility profile.
  • For aqueous dosing, introduce the compound from a DMSO stock into pre-warmed buffer/media and keep DMSO ≤1–2% v/v to limit solvent effects.

Item-specific buffer roles, pKa, and buffering ranges: Not specified for this item; refer to CoA/Spec Sheet.

Green Alternatives

In discovery workflows, solvent choice drives a large proportion of environmental impact. Although item-specific solubility is not provided, the following greener-practice considerations apply to small-molecule handling:

  • Prefer water-rich systems whenever compatible with assay biology. Use minimal DMSO final concentrations (≤1% v/v) to reduce solvent burden.
  • When organic solvents are required, consider:
    • Ethanol over methanol when toxicity and assay tolerance permit.
    • Acetonitrile as an HPLC eluent with efficient recovery; evaluate isocratic methods to minimize solvent use.
    • Avoid chlorinated solvents (e.g., DCM, chloroform) for routine dissolution; reserve only for necessary sample cleanup with engineered controls.
  • Micro-scale operations: Prepare high-concentration master stocks and dispense via acoustic/electronic pinning to minimize solvent volume and waste.
  • Recovery and waste reduction: Segregate high-purity ACN/water waste streams for recycling where infrastructure exists; use solvent-less or minimal-wash solid-phase cleanup instead of liquid–liquid extraction when feasible.

Illustrative comparison (general):

  • DMSO (workhorse, high BP, low volatility) vs 2-MeTHF/CPME (greener ether options) — for biological assays, DMSO remains most compatible; greener ethers are more relevant to synthetic chemistry, not screening stocks.

Always balance green goals with compound stability and assay performance; validate any solvent change with controls and analytical checks.

Pharmaceutical Uses

No pharmacopeial status, excipient role, or formulation guidance is provided for this product. It is supplied strictly for research use only.

  • Not for human or veterinary use, diagnostic procedures, or clinical applications.
  • If used as a discovery-stage test article, any formulation for in vivo research should be developed de novo based on the compound’s structure and properties (solubility, stability, pKa, permeability), with rigorous toxicology appropriate to the model—outside the scope of this listing.
  • Compendial references (USP/EP/JP) and ICH-quality expectations are not applicable unless separately qualified by your organization.

Item-specific pharmaceutical/excipient uses: Not specified for this item; refer to CoA/Spec Sheet.

Physical Properties

Item-specific physical constants are not provided in the Product Data. Do not treat any values below as specifications.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point (MP): Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point (BP): Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • logP/logD, pKa, refractive index: Not specified for this item; refer to CoA/Spec Sheet.

Practical characterization guidance (general, literature best practice):

  • Conduct a quick solubility panel (e.g., 10 mg/mL and 1 mg/mL) in DMSO, MeOH, EtOH, acetonitrile, water, PBS (pH 7.4), and 50:50 cosolvent mixes to identify stock-solution options for assays.
  • Determine kinetic solubility by titrating DMSO stocks into aqueous buffers and measuring turbidity/UV scatter or Nephelometry.
  • If solid, measure melting onset by DSC or capillary MP for identity and polymorph checks; if oil, record viscosity and setpoint for sample handling.
  • For stability, run forced-degradation spot checks (acid/base, oxidative, heat, light) and monitor by LC–UV/MS to identify labile motifs. Document any hydrate/solvate formation.
  • For LC method development, begin with C18, 0.1% formic acid in H2O/MeCN gradient; if basic, test ammonium bicarbonate pH 8–9. Record UV spectrum to identify analytical wavelengths. These are general recommendations only; defer to CoA/SDS for final specifications.
Quality and Grades
  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

Interpretation and expectations (general for screening library compounds):

  • Research/Screening grade small molecules are typically supplied with an accompanying CoA summarizing purity (commonly ≥95% by HPLC/UPLC-UV), identity (LC–MS, HRMS, or NMR), and water/residual solvent content when applicable. Because no grade is listed here, confirm acceptance criteria with your QA policy before use in primary or secondary assays.
  • Analytical package: Expect at minimum LC–MS purity and retention time. For SAR or lead-optimization work, obtain 1H NMR (and 13C NMR if possible) to verify regiochemistry/tautomeric state.
  • UV profile: If the item is intended for chromatographic detection, low baseline drift and absence of major chromophoric impurities are desirable; request UV cut-off or spectral scan if relevant to your method.
  • Impurity/stabilizer content: Not specified for this item; refer to CoA/Spec Sheet. If stabilizers are present (e.g., acid scavengers, antioxidants), they will be listed on the CoA and may influence assay background.
  • Lot-to-lot control: For screening cascades, lock a single lot for comparability or re-bridge activity with orthogonal analytical confirmation upon lot change.
  • Suggested acceptance testing (user): Quick check by UPLC (two-wavelength), LC–MS, and moisture (Karl Fischer) upon receipt to confirm fitness for intended use.
Reaction and Applications

This product is supplied as a screening compound designated “Antimicrobial agent-3” and is not positioned as a general-purpose synthetic reagent. No manufacturer application notes are provided in the Product Data for use in chemical reactions.

  • Synthetic reagent role: Not typically applicable. Without a disclosed functional-group set or stability profile, recommending its use in named reactions or as a building block would be speculative.
  • Research usage (general and non-clinical): The item may serve as a test article or reference compound in discovery biology (e.g., microbial growth inhibition assays) or as an internal control in analytical development. Any biological assessment should include orthogonal counterscreens and solvent controls.
  • If derivatization/SAR is planned: Obtain the chemical structure and IP status. With identity in hand, analog synthesis can be directed toward potency, solubility, metabolic stability, and spectrum tuning; however, such activities require fully characterized starting material and are outside the scope of the current listing.

For laboratory applications that do rely on small molecules as reagents (e.g., cross-coupling, functionalization), select well-characterized reagents with known specifications and literature precedence. Refer to the “Synthetic Utility” section for general SAR/derivatization considerations.

Reaction Conditions

Not applicable. This item is not provided as a synthetic reagent, and no structure or reactivity profile is disclosed.

  • If, after structure disclosure, you intend to derivatize the scaffold, select conditions based on the actual functional group array and literature precedents for that chemotype. Typical small-molecule transformations may involve Pd-catalyzed cross-couplings, nucleophilic substitutions, condensations, or reductive aminations, but only where compatible with the scaffold’s stability windows.

Item-specific reaction temperatures, catalysts, solvents, and yields: Not specified for this item; refer to CoA/Spec Sheet.

Safety and Handling

GHS and hazard statements are not provided for this item. Handle as a potentially hazardous research chemical.

  • GHS classification, pictograms, signal word, H-statements: Not specified for this item; refer to SDS.
  • Primary hazards (general for small organic molecules): May cause irritation to skin, eyes, or respiratory tract. Unknown toxicity—avoid ingestion, inhalation, and contact.
  • PPE: Laboratory coat, safety glasses or face shield, and appropriate chemical-resistant gloves (e.g., nitrile). Use in a fume hood to minimize exposure.
  • Storage: Store at −20°C (per Product Data). Keep container tightly closed, protected from moisture and light. Segregate from strong oxidizers and acids/bases until incompatibilities are known.
  • Handling: Allow vial to equilibrate to room temperature in a desiccator before opening to minimize moisture condensation. If hygroscopicity or light-sensitivity is suspected, work rapidly under dry, low-light conditions.
  • Spill/accidental release (general): Absorb with inert material, collect in chemical waste. Ventilate area. Avoid dust/aerosol formation.
  • First aid (general): Eye/skin contact—rinse with water for ≥15 minutes; remove contaminated clothing. Inhalation—move to fresh air. Ingestion—rinse mouth. Seek medical attention in all exposure cases. Provide SDS to responders.
  • Waste: Dispose according to institutional hazardous waste procedures. Do not release to drains.

Always consult the item-specific SDS for authoritative safety information once available.

Solvent Selection

Item-specific solubility data are not provided. The following guidance reflects common practice for small-molecule screening stocks and analytical work.

  • Primary stock solvent: DMSO is typically preferred due to broad solvating power and assay compatibility at ≤1–2% v/v final concentration. Verify solubility by visual inspection and LC analysis to detect microprecipitation upon dilution.
  • Alternative organic solvents: MeOH and acetonitrile are common for analytical injections; EtOH may be preferable in some biological assays. DMF can solubilize challenging compounds but is less assay-friendly.
  • Aqueous systems: If water solubility is desired, evaluate cosolvent systems (e.g., 20–50% MeOH or ACN in water), pH adjustment (if ionizable), or inclusion of cyclodextrins/surfactants for discovery-stage studies (ensure controls).
  • Polarity/miscibility (general): DMSO, MeOH, EtOH, and ACN are fully miscible with water, enabling serial dilutions. Avoid high cosolvent fractions that perturb biological assays.
  • Practical tips:
    • Prepare concentrated DMSO stocks (e.g., 10–50 mM) at room temperature with sonication if needed; filter sterilize only if chemically stable and non-adsorptive to membranes.
    • For LC method development, start with water/ACN (0.1% FA) gradients; switch to buffered pH if tailing is observed, matching analyte ionization.
    • Record precipitation thresholds during aqueous titration to inform assay design.

Because structure and ionization behavior are unknown for this item, empirical solubility screening is recommended before committing to high-throughput formats.

Storage and Reconstitution
  • Storage conditions (from Product Data): Store at −20°C. Shipments are provided in an ice chest with ice pads to maintain cold chain.
  • Container handling: Keep tightly closed in a dry, inert atmosphere. Allow to warm to room temperature before opening to avoid condensation. Reseal promptly; consider desiccant.
  • Stability: Not specified for this item; refer to CoA/Spec Sheet. Until stability data are available, avoid prolonged exposure to moisture, heat, and light.
  • Reconstitution (general guidance for small-molecule stocks):
    • Prepare a concentrated DMSO stock (e.g., 10–50 mM) if soluble; vortex and, if needed, gentle sonication to aid dissolution.
    • For aqueous use, dilute the DMSO stock into buffer/media with vigorous mixing; keep final DMSO ≤1–2% v/v. Verify absence of precipitation visually and by analytical check if critical.
    • Aliquot single-use portions to minimize freeze–thaw cycles. Store aliquots at −20°C or below as appropriate.
  • Freeze–thaw: Minimize cycles; inspect for precipitation or color change before use.

Item-specific solubility, pH stability, and long-term storage limits: Not specified for this item; refer to CoA/Spec Sheet.

Research Use Note: For research use only.

Structure and Identity

Brief overview: This item is supplied as a small-molecule research compound listed under “Antimicrobial agent-3” for screening applications. Item-specific structural identifiers are not provided in the Product Data.

  • CAS: 1902712-34-8
  • Chemical name: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • Synonyms: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (general guidance):

  • Functional groups, ring systems, heteroatoms, and stereochemistry are not disclosed in the Product Data. If needed for method development (e.g., LC–MS/MS transitions, stability assessment), request the structure or a structure-blinded analytical dossier from the CoA/Spec Sheet.
  • For screening workflows, treat as an unknown heteroatom-containing organic small molecule unless otherwise indicated. Assume potential for multiple hydrogen-bonding motifs and variable lipophilicity; confirm experimentally by logD and solubility screens.

2D structure description (general):

  • Without an available structure, a textual 2D description cannot be provided. For cheminformatics registration, use the CAS number and any internal project code until exact identifiers (SMILES/InChI) are released by your QA system.
Synthetic Utility

Because the structure and functional groups of this compound are not disclosed, specific synthetic transformations cannot be recommended. Nevertheless, for teams exploring structure–activity relationships (SAR) after deconvolution, the following general strategies apply once the scaffold is known:

  • Identify derivatization vectors (positions tolerant to substitution) via docking/MoA hypotheses and preliminary SAR; prioritize solubility-enhancing and efflux-avoidance motifs.
  • Build rapid analog libraries using robust chemistries aligned to the scaffold class (e.g., amide coupling, SNAr, Buchwald–Hartwig, Suzuki–Miyaura, reductive amination), selected only after functional group reconnaissance of the parent structure.
  • Balance properties: Aim for cLogP and polar surface area ranges consistent with cell penetration for the intended organisms, while monitoring off-target liabilities (e.g., membrane disruption vs specific target inhibition).
  • Analytical enablement: Establish a stability-indicating UPLC method early; include chiral separation if a stereogenic center is present in the scaffold.

Item-specific functional groups, named-reaction compatibility, and protecting-group strategies: Not specified for this item; refer to CoA/Spec Sheet.

Target Specificity

Item-specific biological targets, enzyme/pathway specificity, and organism spectrum are not provided.

  • Target, pathway, organism spectrum: Not specified for this item; refer to CoA/Spec Sheet.
  • Any inference about molecular targets or selectivity would be speculative without supporting data. Perform unbiased profiling (e.g., chemoproteomics, resistant mutant mapping, or panel assays) if mechanism elucidation is required in your research program.

Foire aux questions

How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 1902712-34-8, the molecular formula is C14H11N3OS, and the molecular weight is 269.32 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?

Me rappeler plus tard

Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.

Oups ! Les notifications sont désactivées.